Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease

Although there is evidence for metabolic dysfunction and chronic inflammation in Alzheimer's disease (AD), circulating levels of soluble receptor for advanced glycation end products (sRAGE) and the receptor for advanced glycation end products (RAGE) ligand S100B have not been characterized. sRA...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuller, Kelly N. Z., Miranda, Edwin R., Thyfault, John P., Morris, Jill K., Haus, Jacob M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842684/
https://www.ncbi.nlm.nih.gov/pubmed/29681765
http://dx.doi.org/10.1155/2018/2061376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842684/
https://www.ncbi.nlm.nih.gov/pubmed/29681765
http://dx.doi.org/10.1155/2018/2061376

Ejemplares similares